What is the recommended treatment for strep throat?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Strep Throat

Penicillin or amoxicillin for 10 days is the definitive first-line treatment for strep throat, with no documented resistance and proven efficacy in preventing acute rheumatic fever. 1, 2

Diagnostic Confirmation Before Treatment

  • Test patients with 2 or more Centor criteria (fever, tonsillar exudates, tender anterior cervical lymphadenopathy, absence of cough) using rapid antigen detection test (RADT) or throat culture before prescribing antibiotics 1, 2
  • Children under 3 years generally do not require testing unless specific risk factors exist, such as an older sibling with strep infection 1, 2
  • Do not test or treat if viral features predominate (cough, rhinorrhea, hoarseness, conjunctivitis, oral ulcers) 1

First-Line Antibiotic Therapy for Non-Allergic Patients

Penicillin V remains the gold standard due to its narrow spectrum, proven efficacy, safety profile, and low cost, with zero documented resistance over five decades. 1, 2

Dosing Regimens:

Adults:

  • Penicillin V: 500 mg orally twice daily for 10 days 1, 2
  • Alternative: 250 mg four times daily for 10 days 1

Children and adolescents:

  • Penicillin V: 250 mg twice or three times daily for 10 days 1, 2
  • Amoxicillin: 50 mg/kg once daily (maximum 1000 mg) OR 25 mg/kg twice daily (maximum 500 mg per dose) for 10 days 1, 3

Amoxicillin is equally effective and often preferred in children due to better palatability and once-daily dosing option, which enhances adherence. 1, 2, 4

Intramuscular Option:

  • Benzathine penicillin G: Single dose of 600,000 units for patients <27 kg (60 lbs) or 1,200,000 units for patients ≥27 kg when adherence is questionable 1, 2

Treatment for Penicillin-Allergic Patients

Non-Immediate/Non-Anaphylactic Allergy:

First-generation cephalosporins are the preferred alternatives with strong, high-quality evidence and only 0.1% cross-reactivity risk in patients with non-severe, delayed penicillin reactions. 1, 5, 2

  • Cephalexin: 20 mg/kg per dose twice daily (maximum 500 mg per dose) for 10 days in children; 500 mg twice daily for 10 days in adults 1, 5
  • Cefadroxil: 30 mg/kg once daily (maximum 1 gram) for 10 days 1, 5

Immediate/Anaphylactic Allergy:

Clindamycin is the preferred choice with approximately 1% resistance rate in the United States and high efficacy even in chronic carriers. 1, 5, 2

  • Clindamycin: 7 mg/kg per dose three times daily (maximum 300 mg per dose) for 10 days 1, 5

Macrolide Alternatives (with resistance concerns):

  • Azithromycin: 12 mg/kg once daily (maximum 500 mg) for 5 days only 1, 5
  • Clarithromycin: 7.5 mg/kg per dose twice daily (maximum 250 mg per dose) for 10 days 1, 5

Macrolide resistance among Group A Streptococcus ranges from 5-8% in the United States but varies geographically, making clindamycin or first-generation cephalosporins preferred in areas with high resistance. 1, 5, 6

Critical Treatment Duration Requirements

A full 10-day course is mandatory for all antibiotics except azithromycin to achieve maximal pharyngeal eradication of Group A Streptococcus and prevent acute rheumatic fever. 1, 2

  • Azithromycin requires only 5 days due to its prolonged tissue half-life and unique pharmacokinetics 1, 5, 2
  • Therapy can be safely postponed up to 9 days after symptom onset and still prevent acute rheumatic fever 5
  • Shortening the course by even a few days results in appreciable increases in treatment failure rates 5

Adjunctive Symptomatic Treatment

  • Acetaminophen or NSAIDs (ibuprofen) can be used for moderate to severe symptoms or high fever 1, 5
  • Aspirin must be avoided in children due to risk of Reye syndrome 1, 5
  • Corticosteroids are not recommended as adjunctive therapy 1, 5

Common Pitfalls to Avoid

  • Do not use cephalosporins in patients with immediate/anaphylactic penicillin reactions due to up to 10% cross-reactivity risk 1, 5, 2
  • Do not prescribe shorter courses than recommended (except azithromycin's 5-day regimen) as this increases treatment failure and rheumatic fever risk 1, 5, 2
  • Do not use trimethoprim-sulfamethoxazole or tetracyclines as they do not eradicate Group A Streptococcus 1, 5
  • Check local macrolide resistance patterns before prescribing azithromycin or clarithromycin, as resistance varies geographically 5, 2, 6
  • Do not use broad-spectrum cephalosporins (cefdinir, cefpodoxime) when narrow-spectrum first-generation agents are appropriate, as they are more expensive and select for resistant flora 1, 5
  • Avoid ampicillin and amoxicillin if concurrent infectious mononucleosis is suspected, as this causes a characteristic rash in up to 90% of cases 7

Post-Treatment Considerations

  • Routine follow-up throat cultures are not recommended for asymptomatic patients who have completed therapy 1, 7, 2
  • Patients become non-contagious after 24 hours of appropriate antibiotic therapy 7
  • Follow-up testing may be considered only in special circumstances, such as patients with a history of rheumatic fever 5, 2

Special Clinical Situations

Recurrent pharyngitis: Distinguish between true recurrent infections versus chronic carrier state with viral infections; chronic carriers generally do not require antimicrobial therapy as they are unlikely to spread infection and are at little risk for complications 1, 5, 2

Pregnancy: Penicillin and amoxicillin remain first-line with proven safety; for penicillin-allergic pregnant patients, use cephalexin/cefadroxil for non-anaphylactic allergy or clindamycin for anaphylactic allergy 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Pharyngitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Streptococcal Infections in Patients with Penicillin Allergy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Streptococcal Pharyngitis: Rapid Evidence Review.

American family physician, 2024

Guideline

Antibiotic Treatment for Concurrent Strep Pharyngitis and Infectious Mononucleosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.